GlassScriptPhysician profile
Adam D Smith
NPI 1801248489
$3,306.51
in general payments reported to CMS, 2019-2025
26 companies · $621 in 2025
The $621 reported for 2025 was more than what 80% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $1,772 · 2023: $136 · 2024: $561 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,583.26 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $438.18 | 2024-2025 | Indigo System, Ruby Coil |
| Medtronic, INC. | $270.81 | 2021-2025 | Endurant Iis |
| Abbott Laboratories | $255.21 | 2022-2025 | Esprit, Jeti, Diamondback Peripheral |
| Abiomed | $108.19 | 2025 | |
| Pfizer INC. | $71.01 | 2021-2025 | |
| Inari Medical, INC. | $54.12 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Becton, Dickinson and Company | $52.46 | 2024 | Rotarexs 6 F X 135 Cm |
| Tactile Systems Technology INC | $52.30 | 2022 | |
| Janssen Pharmaceuticals, INC | $45.88 | 2021-2024 | Xarelto |
| W. L. Gore & Associates, INC. | $36.59 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Organogenesis INC. | $36.09 | 2024 | |
| Corcym INC | $29.06 | 2025 | Perceval |
| Atricure, INC. | $28.91 | 2024 | |
| Daiichi Sankyo INC. | $28.51 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $28.15 | 2025 | Pico 14, Renasys Touch |
| Inspiremd LTD | $24.42 | 2025 | Cguard Prime Carotid Stent System |
| Trevena, INC. | $23.86 | 2023 | Olinvyk |
| Bard Peripheral Vascular, INC. | $23.02 | 2024 | Denali Vena Cava Filter |
| Triad Life Sciences INC. | $22.51 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $18.40 | 2024 | Eliquis |
| Cardiva Medical, INC. | $17.83 | 2023 | Cardiva Vascade 6/7f Vcs |
| Baxter Healthcare | $16.48 | 2023 | Floseal |
| Aroa Biosurgery Incorporated | $16.35 | 2025 | |
| Kci USA, INC. | $13.09 | 2023 | Activ.A.C., Activ.A.C. Ion Progress |
| Lemaitre Vascular, INC. | $11.82 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.